A toolkit to address disparities in digitally enabled oncology trials By Ogkologos - September 5, 2025 731 0 Facebook Twitter Google+ Pinterest WhatsApp An initiative fosters inclusive research by improving patient access and participation in cancer research Source RELATED ARTICLESMORE FROM AUTHOR FDA Approves Allogeneic Regulatory T Cell-Based Immunotherapy with HSPC and T Cells-vldq for Use in Matched Donor HSCT for Adult Patients with Haematologic Malignancies Combination of mFOLFOX6/Bevacizumab Plus Atezolizumab Prolongs PFS Compared with Atezolizumab in First-Line Treatment of dMMR/MSI-H mCRC Use of YEARS Algorithm, D-dimer Levels, and Performing Risk-Dependent CT Pulmonary Angiography is Safe in Patients with Cancer and Suspected Pulmonary Embolism MOST POPULAR Evidence for the Utility of ctDNA Monitoring for Recurrence After CRC... October 3, 2024 Efficacy of a Bispecific Monoclonal Antibody Glofitamab for Relapsed or Refractory... December 19, 2022 Five Questions With…Stephen. May 5, 2022 Coping with Grief: An Interview with Author Rebecca Munn September 28, 2020 Load more HOT NEWS Age: the forgotten cancer risk factor? Percentage of Cancer Patients Who Are Eligible for and Respond to... ¿Puede el uso de aceites esenciales ayudar a tratar el cáncer... EMA Recommends Extension of Indications for Cemiplimab
